Justin Leong - 20 Nov 2025 Form 4 Insider Report for RESMED INC (RMD)

Reporting relationship: Chief Product Officer
Issuer ticker: RMD
Reported as of: 20 Nov 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 24 Nov 2025, 15:28:40 UTC
Prior SEC filing: 19 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Leong

Key filing fact

Justin Leong filed Form 4 for RESMED INC (RMD) on 24 Nov 2025.

Key facts

This page summarizes Justin Leong's Form 4 filing for RESMED INC (RMD).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 24 Nov 2025, 15:28.

Change

Previous filing in this sequence was filed on 19 Aug 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001825782 Primary reporting owner

Leong Justin

Relationship: Chief Product Officer
Address: 9001 SPECTRUM CENTER BLVD, SAN DIEGO
Signature: /s/ Michael J. Rider, attorney-in-fact for Mr. Leong
Signature date: 21 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

RMD transaction

ReMed Common Stock

Award

Transaction value: $0
Shares: +1,848
Change %: +6.8%
Price: $0.000000
Shares after: 29,028
Date: 20 Nov 2025
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents performance-based restricted stock units granted on November 16, 2022. The shares were earned on November 20, 2025, when the compensation and leadership development committee certified that the performance metrics were met.